REG - Zotefoams PLC - Appointment of Joint Broker <Origin Href="QuoteRef">ZTF.L</Origin>

ZotefoamsAnnouncement

06/01/2017 07:01

RNS Number : 4920T
Zotefoams PLC
06 January 2017
Zotefoams plc
("Zotefoams" or "the Company")
Appointment of Joint Broker
6 January 2017 - Zotefoams, a world leader in cellular materials technology, today announces the appointment of Arden Partners plc to act as its joint broker alongside Investec Bank plc, with immediate effect. 
- Ends -
Enquiries:
Zotefoams plc 
+44 (0)208 664 1600
David Stirling, Group CEO

Gary McGrath, Finance Director



FTI Consulting 
+44 (0)203 727 1000
Victoria Foster Mitchell / Simon Conway

About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE polyolefin and ZOTEK high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide. 
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT). 
www.zotefoams.com
AZOTE, ZOTEK, T-FIT are registered trademarks of Zotefoams plc
MuCell is a registered trademark of Trexel Inc.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
APPBAMTTMBTMTFR